Product/Composition:- | Clindamycin topiccal cream/ointment |
---|---|
Strength:- | 1%, 2% |
Form:- | Topical Creams and Ointments |
Reference Brands:- | Cleocin, Clindamycin, Dalacin C(US); Dalacin C, Clindamycine(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Clindamycin ointment and creams inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing bacterial growth. They effectively treat acne, skin infections, and abscesses. Benefits include targeted topical therapy, rapid relief of skin symptoms, minimal systemic absorption, and a favorable safety profile when used as directed.
Clindamycin ointment and creams are approved in the EU and US for treating acne and bacterial skin infections. In the EU, brands like Clindacne are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for clindamycin topical formulations, ensuring adherence to European and US standards for safe, effective dermatological therapy.